.
the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid..
..
biohaven: "rimegepant pivotal phase 3 trial results -- conference call.".
.
.
.exploding e-cigarette killed florida man, coroner says.
"we were quite surprised to find there were no significant differences," says study author.